norinyl-1 28 day tablet blister pack
pfizer australia pty ltd - norethisterone, quantity: 1 mg; mestranol, quantity: 51.5 microgram - tablet, uncoated - excipient ingredients: povidone; lactose monohydrate; maize starch; magnesium stearate - indications as at 23rd january 1998: oral contraception. norinyl-1 is an agent for conception control.
apo-megestrol
apotex nz ltd - megestrol acetate 160mg - tablet - 160 mg - active: megestrol acetate 160mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).
apo-megestrol
apotex nz ltd - megestrol acetate 40mg - tablet - 40 mg - active: megestrol acetate 40mg excipient: brilliant blue fcf colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - apo-megestrol is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e. recurrent, inoperable or metastatic diseases). it should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy. apo-megestrol is indicated for the treatment of anorexia, cachexia, or a significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids).
flomaxtra
seqirus (nz) ltd - tamsulosin hydrochloride 400ug; - modified release tablet - 400 mcg - active: tamsulosin hydrochloride 400ug excipient: hypromellose macrogol 7,000,000 (incl. 0.2mg butylated hydroxytoluene; 6.0mg collodial anhydrous silica) iron oxide yellow macrogol 8000 magnesium stearate
tamsulosin hydrochloride
douglas pharmaceuticals limited - tamsulosin hydrochloride 0.4mg - capsule - 0.4 mg - active: tamsulosin hydrochloride 0.4mg excipient: brilliant blue fcf carmoisine gelatin talc (extragranular ingredients) ink iron oxide yellow magnesium stearate methacrylic acid - ethyl acrylate copolymer microcrystalline cellulose ponceau 4r purified talc quinoline yellow sodium hydroxide sunset yellow fcf titanium dioxide triacetin
tamsulosin
rex medical ltd - tamsulosin hydrochloride 0.4mg (plus 2% overage) - modified release capsule - 0.4 mg - active: tamsulosin hydrochloride 0.4mg (plus 2% overage) excipient: colloidal silicon dioxide hypromellose hypromellose (hpmc 6 cps) ethyl cellulose aqueous dispersion (surelease e-7-7050) methacrylic acid copolymer usp (type c) eudragit l30d-55 (aqueous dispersion) polysorbate 80 propylene glycol purified talc sugar spheres triethyl citrate - treatment of functional symptoms of benign prostatic hyperplasia (bph).
omnic ocas 0.4
cts ltd - tamsulosin hydrochloride - tablets prolonged release, film coated - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - lower urinary tract symptoms ( luts) associated with benign prostatic hyperplasia (bph).
combodart 0.5 mg/ 0.4 mg hard capsules
glaxosmithkline (ireland) limited - dutasteride; tamsulosin hydrochloride - capsule, hard - 0.5 mg/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and dutasteride
kirnom xl 400 micrograms prolonged-release hard capsules
wockhardt uk limited - tamsulosin hydrochloride - prolonged-release capsule, hard - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin
megace 40 milligram tablets
bristol-myers squibb (holdings) limited - megestrol acetate - tablets - 40 milligram